Risk of cancer after use of fertility drugs with in-vitro fertilisation (Q34505781)

2 August 2017

Risk of cancer after use of fertility drugs with in-vitro fertilisation (English)

1 reference

2 August 2017

4

1 reference

2 August 2017

A Venn

1

1 reference

2 August 2017

L Watson

series ordinal

2

1 reference

2 August 2017

F Bruinsma

series ordinal

3

1 reference

2 August 2017

D Healy

series ordinal

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

2 August 2017

1 reference

2 August 2017

354

1 reference

2 August 2017

9190

1 reference

2 August 2017

1586-1590

1 reference

Transient Increase in the Risk of Breast Cancer after Giving Birth

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

Time since childbirth and prognosis in primary breast cancer: population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

Risk of breast cancer in a cohort of infertile women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

Cancer incidence in a cohort of infertile women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

Fertility drugs and the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

Infertility: Fertility drugs and risk of epithelial ovarian cancer in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

Infertility, fertility drugs, and invasive ovarian cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

Ovarian tumors in a cohort of infertile women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

Human menopausal gonadotropin and the risk of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

Breast and ovarian cancer incidence after infertility and in vitro fertilisation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

Fertility drugs and breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2905203-4

7 January 2021

10.1016/S0140-6736(99)05203-4

Identifiers

DOI

1 reference

2 August 2017

1 reference